LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

Home・Listă Acțiuni・NeoGenomics Inc

NeoGenomics Inc

Închisă

8.88 0.34

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

8.44

Maxim

8.96

Indicatori cheie
By Trading Economics
Venit	-7.2M -17M
Vânzări	-3.5M 187M
EPS	0.01
Marjă de profit	-9.164
Angajați	2,500
EBITDA	-5.8M -567K

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+66% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	51M 1.2B
Deschiderea anterioară	8.54
Închiderea anterioară	8.88

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

7.7 / 10.27 Suport & Rezistență

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 mai 2026, 20:33 UTC

Câștiguri

Strategy Reports Wider 1Q Loss on Lower Value of Bitcoin

5 mai 2026, 11:15 UTC

Câștiguri

PayPal to Cut Costs After 1Q Profit Falls

5 mai 2026, 21:26 UTC

Câștiguri

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

5 mai 2026, 21:15 UTC

Câștiguri

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

5 mai 2026, 18:56 UTC

Market Talk

Bitcoin Holds Over $80K Mark, Opening the Door to $85K -- Market Talk

5 mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

5 mai 2026, 16:13 UTC

Market Talk

Institutions Buying Bitcoin En Masse -- Market Talk

5 mai 2026, 15:30 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

5 mai 2026, 15:30 UTC

Market Talk

Clarity Act Compromise Supporting Crypto -- Market Talk

5 mai 2026, 15:06 UTC

Achiziții, Fuziuni, Preluări

Why Crypto Exchange Bullish Is Making a $4 Billion Bet on Transfer Agents -- Barrons.com

5 mai 2026, 14:57 UTC

Market Talk

Bitcoin Could Extend Gains But Investors Should Be Cautious -- Market Talk

5 mai 2026, 14:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 mai 2026, 14:07 UTC

Market Talk

Stronger Institutional, ETF Demand Helps Boost Bitcoin -- Market Talk

5 mai 2026, 10:13 UTC

Achiziții, Fuziuni, Preluări

Bullish: $4.2B Deal Comprises $1.85B of Assumed Equiniti Debt, About $2.35B in Bullish Stock Consideration >BLSH

5 mai 2026, 10:12 UTC

Achiziții, Fuziuni, Preluări

Bullish to Acquire Equiniti From Siris in $4.2B Transaction

5 mai 2026, 10:00 UTC

Achiziții, Fuziuni, Preluări

Crypto Exchange Bullish Strikes $4.2 Billion Deal for Transfer Agent in Tokenization Push -- WSJ

5 mai 2026, 10:00 UTC

Achiziții, Fuziuni, Preluări

Equiniti Services Nearly 3,000 Public Companies Including Berkshire Hathaway and Moody's -- WSJ

5 mai 2026, 10:00 UTC

Achiziții, Fuziuni, Preluări

Bullish Transaction for Equiniti Expected to Close in January Pending Regulatory Approvals -- WSJ

5 mai 2026, 10:00 UTC

Achiziții, Fuziuni, Preluări

Crypto Exchange Bullish to Buy Transfer Agent Equiniti for $4.2 Billion, Including Debt -- WSJ

5 mai 2026, 07:20 UTC

Market Talk

Bitcoin Rises to Three-Month High, Holding Above Key $80,000 Level -- Market Talk

4 mai 2026, 18:18 UTC

Market Talk

Bitcoin Pushes Over $80k as Oil-BTC Relationship Steps Aside -- Market Talk

4 mai 2026, 14:38 UTC

Market Talk

Bitcoin Stuck Between Narratives -- Market Talk

4 mai 2026, 14:21 UTC

Market Talk

Bitcoin Below $80k Resistance -- Market Talk

1 mai 2026, 19:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 mai 2026, 19:33 UTC

Market Talk

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 mai 2026, 17:37 UTC

Market Talk

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 mai 2026, 16:38 UTC

Market Talk

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 mai 2026, 15:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

66% sus

Prognoză pe 12 luni

Medie 14.94 USD 66%

Maxim 25 USD

Minim 11 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 12 analiști care au acordat evaluări ale acțiunilor NeoGenomics Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

7.7 / 10.27Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bearish.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.